Zensar Technologies (504067) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
30 Jul, 2026Executive summary
Q1 FY27 revenue reached $159.5 million (₹15,083 million), up 1.1% sequentially in constant currency and 8.9% year-over-year in INR terms, with strong BFSI and AI-native offerings driving growth.
PAT margin stood at 12.2%, declining 220 bps sequentially, with net profit after tax at ₹1,838 million.
Workforce expanded by 5.2% sequentially, voluntary attrition at 9.6% for the sixth consecutive quarter.
Order book at $149.2 million (INR 149.2 million), up 62.9% QoQ.
Ranked #1 in IT Services sector and #6 overall in India's Best Companies to Work For 2026.
Financial highlights
EBITDA margin contracted by 150 bps sequentially to 14.6% due to pre-staffing, transition costs, and increased travel, visa, and training expenses.
Diluted EPS at INR 8 per share (basic EPS ₹8.11), up 0.9% year-over-year.
Cash and investments at $317.5 million (₹317.5 million), with a $2.0 million decrease QoQ.
Top 5 clients contributed 24.7% of revenue, top 10 clients 38.9%, and top 20 clients 56.6%.
Total assets as of June 30, 2026, were ₹61,839 million.
Outlook and guidance
Full revenue impact from the $210 million mega BFSI deal expected in Q3 and Q4, with continued ramp-up in Q2.
Margins expected to remain at Q1 levels for Q2 and Q3 due to ongoing investments in SG&A, AI capabilities, and deal ramp-up.
No further impact from Labour Code changes is expected; focus remains on AI-native transformation and disciplined execution.
Management highlighted strong order book momentum and continued focus on AI-driven solutions.
Latest events from Zensar Technologies
- Q3 FY25 revenue up 8.6% YoY to $157.0M, with 15.6% EBITDA margin and record order book.504067
Q3 24/259 Jul 2026 - Record order book and profit growth in FY26, with final dividend of ₹12.60 per share recommended.504067
Q4 25/268 Jul 2026 - Q4 FY25 saw 6.3% YoY revenue growth, higher PAT margin, strong order book, and increased dividends.504067
Q4 24/258 Jul 2026 - Record order book, stable margins, and strong BFSI/healthcare growth; BridgeView acquired.504067
Q2 24/2519 Jun 2026 - Q1 FY26 revenue up 4.9% YoY to $162M, with strong AI and digital/cloud growth but margin pressures.504067
Q1 25/2619 Jun 2026 - AI-driven growth, robust financials, and ESG leadership marked FY26 performance.504067
Investor presentation26 May 2026 - Q3 FY26 saw revenue and margin growth, strong order book, and continued AI-driven investments.504067
Q3 25/2623 Jan 2026 - Q2 revenue up 4.2% YoY to $162.8M, with margin gains, AI momentum, and TMT headwinds.504067
Q2 25/262 Nov 2025